1Schaifer-Korting M. New systemic antifungal drugs: mechanisms of action, drug interactions and side effects [J]. Mycoses, 2003, 46(Suppl 1):28-31.
2Wood N, Tan K, Purkins L, et al. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole [ J ]. Br J Clin Pharmacol, 2003, 56(Suppl 1) :56-61.
3Mendila M, Waiter GF, Stoll M, et al. Rhabdomyolysis in antiretroviral therapy with Lamivudin [ J]. Dtsch Med Wochenschr, 1997, 122 (33) : 1003-1006.
4Pasqualotto AC, Xavier MO, Andreolla HF, et al. Voriconazole therapeutic drug monitoring: focus on safety [ J ]. Exper Opin Drug Saf, 2010, 9( 1 ) : 125-137.
5Boussaud V, Daudet N, Billaud EM, et al. Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus [ J]. J Heart Lung Transplant, 2008, 27 (2) :229-232.
7Katz RL,Shirkhoda A. Diagnostic approach to adrenal nodules in the cancer patient. Cancer, 1995,55 (6): 1995-2000
8Paul R,Mardhorst J,Busch R,et al. Adrenal sparing Surgery during radical nephrectomy in patients with ienal cell cancer:a new algarithm. J Urol,2001,166( 1 ) :59-62
9Sagalowsky Al, Kadesky KT, Ewalt DM, et al. Factors influencing adrenal metastasis in renal cell carcinoma. J Urol, 1994,151 (3):1181-1184
10Ben-AmiR, Lewis RE, Kontoyiannis DP. Immunocompro-mised hosts. Immunopharmacology of modem antifungals[J]. Clin Infect Dis,2008,47(2) 226.
